Rebecca Lei
Lawyers
Filters
Recursion Pharmaceuticals $300 million at-the-market offering
We advised the sales agent on the offering
Maze Therapeutics $200 million at-the-market offering
We advised the sales agent on the offering
Strive $208.8 million preferred stock follow-on offering and private exchanges
We advised Strive on the transactions
Denali Therapeutics $200 million stock and pre-funded warrants offering
We advised the representatives of the several underwriters on the offering
Strive $500 million at-the-market preferred offering
We advised Strive on the offering
Teamshares $126 million PIPE financing and de-SPAC transaction
We advised the placement agent on the transaction
Strive $200 million preferred stock IPO
We advised Strive on its Nasdaq listing of preferred stock
Strive Nasdaq listing and $450 million at-the-market offering
We advised Strive on its Nasdaq listing and offering
Atara Biotherapeutics registered direct offering
The stock is listed on Nasdaq
SoundHound AI $250 million at-the-market offering
The shares are listed on the Nasdaq Global Market